Sanofi (SAN.PA)
Develops and sells vaccines and medicines for diseases like cancer, rare conditions, and infections.
79.38+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-1.2%
The outlook
Sanofi trades at €79.38 with analyst consensus leaning Buy across 23 firms, and the average price target sits roughly 21% above the current level. The stock sits in the lower-middle portion of its 52-week range with mixed momentum against moving averages, suggesting neither clear uptrend nor downtrend at present. A trailing P/E of 20 places it at a moderate valuation relative to earnings.
What’s behind the score
Analyst consensusBuy — 2.1 avg of 23 analysts
Price trendMixed vs its moving averages
52-week range41% of the way from its 52-week low to high
Price targetAvg target +21% vs current price
Analyst price target
~12-month · 23 analysts96.14average target+21.1% vs now
Now 79.38
Low 82.00High 112.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$95.01B
52-wk high
91.15
52-wk low
71.25
50-day avg
75.71
200-day avg
80.04
Trailing P/E
20.0